Prosecution Insights
Last updated: October 26, 2026

Mark Holcomb, USPTO Patent Examiner

Listed by the USPTO as HOLCOMB, MARK

Tech Center 3700 • Art Units: 3626 3685 3686 3785

This examiner grants 33% of resolved cases

Analysis

HOLCOMB, MARK is a USPTO patent examiner in Tech Center 3700 and art unit 3626. The profile records 494 resolved cases, a 33.4% allowance rate, a 40.0% interview lift, and a median of 1610 days to allowance. The interview measure exceeds the allowance figure as a percentage, so it should be read as an association with outcome changes rather than as an allowance probability.

The listed companies are DEKA Products Limited Partnership, Samsung Electronics Co., Ltd., and ORACLE INTERNATIONAL Corporation. The associated firms are FisherBroyles, LLP, SUGHRUE MION, PLLC, and Bookoff McAndrews, PLLC. The median timing supports early budgeting and careful management of prosecution expectations.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

33.4%
Allow Rate
-36.6% vs TC avg
551
Total Applications
+40.0%
Interview Lift
1610
Avg Prosecution Days
Based on 494 resolved cases, 2023–2026

Rejection Statute Breakdown

28.8%
§101 Eligibility
7.1%
§102 Novelty
40.4%
§103 Obviousness
22.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18667808 METHOD OF PROVIDING HEALTH CARE SERVICE, SERVER AND HEALTH CARE DEVICE Final Rejection SAMSUNG ELECTRONICS CO., LTD.
18202687 METHOD AND SYSTEM FOR MITIGATING PHYSICAL RISKS IN AN IOT ENVIRONMENT Final Rejection SAMSUNG ELECTRONICS CO., LTD.
19368835 SYSTEMS AND METHODS FOR GENERATING CLINICAL HANDOFF SUMMARIES Non-Final OA Oracle International Corporation
19368660 SYSTEMS AND METHODS FOR GENERATING CLINICAL SUMMARIES Non-Final OA Oracle International Corporation
19047855 SYMPTOM UNDERSTANDING ASSIST APPARATUS, SYMPTOM UNDERSTANDING ASSIST METHOD, AND RECORDING MEDIUM Final Rejection NEC Corporation
19086276 BREAST CANCER RISK PREDICTION DEVICE AND METHOD Final Rejection SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
19173916 MEDICAL SYSTEM FOR DOCUMENTING AND MANAGING A DRUG ADMINISTRATION PROCEDURE, METHOD OF DOCUMENTING AND MANAGING A DRUG ADMINISTRATION PROCEDURE, AND COMPUTER PROGRAM Non-Final OA B. Braun Melsungen AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Mark Holcomb's allowance rate?

33.4% of resolved applications examined by Mark Holcomb were allowed (494 resolved cases), compared with 24.6% across Art Unit 3626 over the last five years.

Does an interview help with examiner Mark Holcomb?

This examiner's interview lift is +40.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Mark Holcomb take to allow a patent?

Applications allowed by Mark Holcomb took 1,610 days on average from filing to allowance.

Which art unit does examiner Mark Holcomb work in?

Mark Holcomb examines applications in Art Unit 3626 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month